Le JOG a lu pour vous

Kenzik et al. New-Onset Cardiovascular Morbidity in Older Adults With Stage I to III Colorectal Cancer 1

S. Muxel

Voir le résumé

Frasca et al. Alterations in comprehensive geriatric assessment decrease survival of elderly patient with cancer 1

S. Azan

Voir le résumé

Wildiers et al. Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group 1

S. Azan, S. Muxel, M. Vinches

Voir le résumé

Chin-Yee N, et al. Cost analysis of the very elderly admitted to intensive care units

I. Leonard-Lorant

Voir le résumé

Agar MR, et al. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial

P. Trensz

Voir le résumé

Ghosh S, et al. Improved cost-effectiveness of short-course radiotherapy in elderly and/or frail patients with glioblastoma

M. Loo

Voir le résumé

Swanick CW, et al. Long-Term Patient-Reported Outcomes in Older Breast Cancer Survivors: A Population-Based Survey Study

W. Waissi

Voir le résumé

Cabannes-Hamy A, et al. Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies

L. Bender

Voir le résumé

Daste A, et al.Immune checkpoint inhibitors and elderly people: A review

S. Azan, S. Muxel, M. Vinches

Voir le résumé

Falandry C, et al. Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial 1

O. Le Saux

Lire l'Article

Alibhai SM, et al. Long-term impact of androgen-deprivation therapy on physical function and quality of life 1

Christophe Sajous

Lire l'Article

Minniti G, et al. Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis 1

Ariane Lapierre

Lire l'Article

Kunkler IH, et al. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial 1

Audrey Claren

Lire l'Article

Chargari C, et al. Feasibility of radiation therapy in patients 90 years of age and older: A French multicentre analysis 1

Alexander Falk

Lire l'Article

Martin N, et al.High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma 1

Juliette Reure

Lire l'Article

Vamvakas L, et al. Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG) 1

Guillaume Beinse

Lire l'Article

Chavez-MacGregor M, et al. Trastuzumab-related cardiotoxicity among older patients with breast cancer 1

G. Cogniet, ASIO

Lire l'Article

Adamo V, et al. The risk of toxicities from Trastuzumab, alone or in combination, in an elderly breast cancer population 1

E.Chartron, ASIO

Lire l'Article

Cunningham D, et al. Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial 1

E.Deluche, ASIO

Lire l'Article

Hoppe S, et al. Functional decline in older patients with cancer receiving first-line chemotherapy

S.Bétrian, ASIO

Lire l'Article

Wildiers H, et al. End Points and Trial Design in Geriatric Oncology Research: A Joint European Organisation for Research and Treatment of Cancer–Alliance for Clinical Trials in Oncology–International Society of Geriatric Oncology Position Article 1

Camille Chakiba, ASIO

Lire l'Article

Hershman DL, et al. Contraindicated Use of Bevacizumab and Toxicity in Elderly Patients With Cancer

Juliette Reure

Lire l'Article

Aparicio T, et al. Geriatric factors predict chemotherapy feasibility: Ancillary results of FFCD 2001-02 Phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly

Audrey Claren

Lire l'Article

Trebouet A, et al. Lymphoma occuring in patients over 90 years of age: charactecristics, outcomes and prognostic factors. A retrospective analysis of 234 cases from the LYSA

AT. Falk

Lire l'Article

D. Garbay, et al. Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival

O. Le Saux

Lire l'Article

Aparicio T, et al. Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First-Line Chemotherapy for Metastatic Colorectal Cancer in Elderly Patients

R. Tanguy

Lire l'Article

Perri T, et al. Treating Gynecologic Malignancies in Elderly Patients

N. Marques

Lire l'Article

Aparicio T, et al. Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First- Line Chemotherapy for Metastatic Colorectal Cancer in Elderly Patients

O. Le Saux

Lire l'Article

Deschler B, et al. Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome

N. Marques

Lire l'Article

Howrey BT, et al. The Impact of PSA Screening on Prostate Cancer Mortality and Overdiagnosis of Prostate Cancer in the United States

R. Tanguy

Lire l'Article

Park JH, et al. Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract

O. Le Saux

Lire l'Article

Kenis C, et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study

R. Tanguy

Lire l'Article

Lire l'Article

Lire l'Article

Lire l'Article

Lire l'Article

Lire l'Article

Lire l'Article

Aizer AA, et al. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer

N. Marques

Lire l'Article

Malmström A, et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma : the Nordic randomised, phase 3 trial

R. Tanguy

Lire l'Article

Kluin-Nelemans HC, et al. Treatment of older patients with mantle-cell lymphoma

O. Le Saux

Lire l'Article

Jehn CF, et al. Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer

A. Ploquin

Lire l'Article

Proctor SJ, et al. Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study

O. Le Saux

Lire l'Article

Maemondo M, et al. First-Line Gefitinib in patients aged 75 and older with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations – NEJ003 Study

C. Baldini

Lire l'Article

Bonomi MR, et al. Outcomes of elderly patients with stage IIIB-IV non-small cell lung cancer admitted to the intensive care unit

N. Marques

Lire l'Article

Extermann M, et al. Predicting the risk of chemotherapy toxicity in older Patients : the Chemotherapy Risk Assessment Scale for High-age patients (CRASH) score

S. Cousin

Lire l'Article

Soubeyran P, et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer

R. Tanguy

Lire l'Article

Jilani OK, et al. Radiation therapy is well tolerated and produces excellent local control rates in elderly patients with locally advanced head and neck cancers

X. Liem

Lire l'Article

Wilt TJ, et al. Radical prostatectomy versus observation for localized prostate cancer

R. Tanguy

Lire l'Article

Abraham et al. : Adjuvant chemotherapy for stage III colon cancer in the oldest old

J. Wassermann

Lire l'Article

Zhu J et al. : Carboplatin and Paclitaxel With vs Without Bevacizumab in Older Patients With Advanced Non–Small Cell Lung Cancer

R. Geiss

Lire l'Article

Soubeyran P et al. : Predictors of early death risk in older patients treated with first-line chemotherapy for cancer

J. Wassermann

Lire l'Article

Atagi et al. : Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)

F.-G. Riet

Lire l'Article

Biganzoli L et al. : Management of elderly patients with breast cancer : updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)

Lire l'Article

Perez-Larraya JG et al. : Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial

Lire l'Article

Van de Water W et al. : Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer

Lire l'Article

Zhu J, et al. : Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer

Lire l'Article

Peyrade F, et al : Schéma immuno-chimiothérapique atténué (R-miniCHOP) chez les patients âgés de plus de 80 ans avec un lymphome B diffus à grandes cellules : une étude de phase 2, multicentrique, en un seul bras

Lire l'Article

Seymour MT, et al. : Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2) : an open-label, randomised factorial trial

Lire l'Article

Perez-Larraya, et al. : Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status : An ANOCEF Phase II Trial

Lire l'Article

Hurria, et al. : Predicting Chemotherapy Toxicity in Older Adults With Cancer : A Prospective Multicenter Study

Lire l'Article

Caillet et al. : Comprehensive Geriatric Assessment in the Decision-Making Process in Elderly Patients With Cancer : ELCAPA Study

Lire l'Article